Successful nonoperative management of gastrointestinal mucormycosis: Novel therapy for invasive disease

Surgical Infections

Volumn 10, Issue 5, 2009, Pages 447-451

  Mezhir, James J ^a   Mullane, Kathleen M ^b   Zarling, Joel ^a   Satoskar, Rohit ^b   Pai, Rish K ^b   Roggin, Kevin K ^a  

^a Section of General Surgery   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CILASTATIN PLUS IMIPENEM; FLUCONAZOLE; OMEPRAZOLE; POSACONAZOLE; STEROID; VANCOMYCIN;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; DEBRIDEMENT; EARLY DIAGNOSIS; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL MUCORMYCOSIS; HIGH RISK PATIENT; HUMAN; MALE; MORBIDITY; MORTALITY; MUCORALES; MUCORMYCOSIS; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DRUG THERAPY, COMBINATION; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; MUCOR; MUCORMYCOSIS; TREATMENT OUTCOME; TRIAZOLES;

EID: 72449195756     PISSN: 10962964     EISSN: None     Source Type: Journal    
DOI: 10.1089/sur.2008.049     Document Type: Article

References (34)

1. Nucci M. Emerging molds: Fusarium, Scedosporium and Zygomycetes in transplant recipients. Curr Opin Infect Dis 2003;16:607-612.
2. Bouza E, Munoz P, Guinea J. Mucormycosis: An emerging disease? Clin Microbiol Infect 2006;12(suppl 7):7-23.
3. Kahn LB. Gastric mucormycosis: Report of a case with a review of the literature. S Afr Med J 1963;37:1265-1269.
4. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormcosis: Pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18:556-569.
5. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005;41:634-653.
6. Paulo de Oliveira JE, Milech A. A fatal case of gastric mucormycosis and diabetic ketoacidosis. Endocr Pract 2002;8: 44-46.
7. Lawson HH, Schmaman A. Gastric phycomycosis. Br J Surg 1974;61:743-746.
8. Gock M, Schafer M, Perren A, et al. Fatal esophageal perforation caused by invasive candidiasis. Ann Thorac Surg 2005;80:1120-1122.
9. Mohite U, Kell J, Haj MA, et al. Invasive aspergillosis localised to the colon presenting as toxic megacolon. Eur J Haematol 2007;78:270-273.
10. Cherney CL, Chutuape A, Fikrig MK. Fatal invasive gastric mucormycosis occurring with emphysematous gastritis: Case report and literature review. Am J Gastroenterol 1999;94: 252-256.
11. Park YS, Lee JD, Kim TH, et al. Gastric mucormycosis. Gastrointest Endosc 2002;56:904-905.
12. Stamm B. Mucormycosis of the stomach in a patient with multiple trauma. Histopathology 2005;47:222-223.
13. Virk SS, Singh RP, Arora AS, et al. Gastric zygomycosis-An unusual cause of massive upper gastrointestinal bleed. Indian J Gastroenterol 2004;23:146-147.
14. Azadeh B, McCarthy DO, Dalton A, Campbell F. Gastrointestinal zygomycosis: Two case reports. Histopathology 2004;44:298-300.
15. Thomson SR, Bade PG, Taams M, Chrystal V. Gastrointestinal mucormycosis. Br J Surg 1991;78:952-954.
16. Ju JH, Park HS, Shin MJ, et al. Successful treatment of massive lower gastrointestinal bleeding caused by mixed infection of cytomegalovirus and mucormycosis in a renal transplant recipient. Am J Nephrol 2001;21:232-236.
17. Shahapure AG, Patankar RV, Bhatkhande R. Gastric mucormycosis. Indian J Gastroenterol 2002;21:231-232.
18. Prasad N, Ram R, Satti Reddy V, Dakshinamurty KV. Nonfatal gastric mucormycosis in a renal transplant patient and review of the literature. Transplant Infect Dis 2006;8:237-241.
19. Vera A, Hubscher SG, McMaster P, Buckels JA. Invasive gastrointestinal zygomycosis in a liver transplant recipient: Case report. Transplantation 2002;73:145-147.
20. Bohme A, Ruhnke M, Buchheidt D, et al; Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Treatment of fungal infections in hematology and oncology-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 2003;82(suppl 2):S133-S140. (Pubitemid 37265300)
21. Ben-Eliyahu S, Page GG, Yirmiya R, Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer 1999;80:880-888.
22. Ni Choileain N, Redmond HP. Cell response to surgery. Arch Surg 2006;141:1132-1140.
23. Da Costa ML, Redmond HP, Finnegan N, et al. Laparotomy and laparoscopy differentially accelerate experimental flank tumour growth. Br J Surg 1998;85:1439-1442.
24. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother 2006;50:126-133.
25. Van Burik JA, Hare RS, Solomon HF, et al. Posaconazole is effective as salvage therapy in zygomycosis: A retrospective summary of 91 cases. Clin Infect Dis 2006;42:e61-e65.
26. Raad II, Graybill JR, Bustamante AB, et al. Safety of long-- term oral posaconazole use in the treatment of refractory invasive fungal infections. Clin Infect Dis 2006;42:1726-1734.
27. Ullmann AJ, Cornely OA, Burchardt A, et al. Pharmacokinetics, safety, and efficacy of posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection. Antimicrob Agents Chemother 2006;50:658-666.
28. Paltauf A. Mycosis mucorina: Ein Beitrag zur Kenntniss der menshlichen Fadenpilzer Krankugen. Virchows Arch Pathol Anat 1885;102:543-563.
29. Deal WB, Johnson JE 3rd. Gastric phycomycosis: Report of a case and review of the literature. Gastroenterology 1969;57: 579-586.
30. Abramowitz I. Fatal perforations of the stomach due to mucormycosis of the gastro-intestinal tract. S Afr Med J 1964;38:93-94.
31. Bouchara JP, Oumeziane NA, Lissitzky JC, et al. Attachment of spores of the human pathogenic fungus Rhizopus oryzae to extracellular matrix components. Eur J Cell Biol 1996;70:76-83.
32. Ullmann AJ, Lipton JH, Vesole DH, et al. Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. N Engl J Med 2007;356:335-347.
33. Cornely OA, Maertens J, Winston DJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007;356:348-359.
34. Keating GM. Posaconazole. Drugs 2005;65:1553-1567.